AMOROLFIN Leman 5%
AMOROLFIN Leman 5% is a medicine authorised by Swissmedic under authorisation number 68231. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 September 2021 and the authorisation is valid without a time limit. ATC code D01AE16 places the medicine in the group Antifungals for dermatological use.
| Authorisation number | 68231 |
|---|---|
| Name | AMOROLFIN Leman 5% |
| Full name | AMOROLFIN Leman 5%, vernis à ongles |
| Authorisation holder | Leman SKL SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D01AE16 |
| First authorisation | 01 September 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | AMOROLFIN Leman 5%, vernis à ongles | B | 01 September 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2.5 | ml | D01AE16 | 10.09.4. | B |
| 2 | 5 | ml | D01AE16 | 10.09.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is AMOROLFIN Leman 5% authorised in Switzerland?
Yes. AMOROLFIN Leman 5% is authorised by Swissmedic under authorisation number 68231, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does AMOROLFIN Leman 5% have?
AMOROLFIN Leman 5% is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of AMOROLFIN Leman 5%?
The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.